Found: 34
Select item for more details and to access through your institution.
Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae387
- By:
- Publication type:
- Article
Effect of Monoclonal Antibody Treatment on Clinical Outcomes in Ambulatory Patients With Coronavirus Disease 2019.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab315
- By:
- Publication type:
- Article
1272. Feasibility and Successful Enrollment in Proof-of-Concept Trials to Assess Safety and Efficacy of a Broadly Neutralizing Monoclonal Antibody, VRC01, to Prevent HIV-1 Acquisitionin in Uninfected Individuals.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S457, doi. 10.1093/ofid/ofz360.1135
- By:
- Publication type:
- Article
Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 1, p. N.PAG, doi. 10.1093/ofid/ofy352
- By:
- Publication type:
- Article
Biphasic Zika Illness With Rash and Joint Pain.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 3, p. 1, doi. 10.1093/ofid/ofx133
- By:
- Publication type:
- Article
Pericarditis Associated With Acute Zika Virus Infection in a Returning Traveler.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 2, p. 1, doi. 10.1093/ofid/ofx103
- By:
- Publication type:
- Article
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 3, p. 1, doi. 10.1093/ofid/ofv082
- By:
- Publication type:
- Article
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.
- Published in:
- Open Forum Infectious Diseases, 2014, v. 1, n. 3, p. 1
- By:
- Publication type:
- Article
Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women.
- Published in:
- Journal of the International AIDS Society, 2023, v. 26, n. 6, p. 1, doi. 10.1002/jia2.26118
- By:
- Publication type:
- Article
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP ® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 741, doi. 10.3390/vaccines8040741
- By:
- Publication type:
- Article
Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 348, doi. 10.3390/vaccines8030348
- By:
- Publication type:
- Article
Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 126, doi. 10.3390/vaccines8010126
- By:
- Publication type:
- Article
DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0125914
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of Adjuvants on the Immunogenicity and Efficacy of Split-Virion H7N9 Vaccine in Ferrets.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 4, p. 542, doi. 10.1093/infdis/jiv099
- By:
- Publication type:
- Article
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 5, p. 818, doi. 10.1093/infdis/jit236
- By:
- Publication type:
- Article
Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons.
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 6, p. 811, doi. 10.1093/infdis/jis427
- By:
- Publication type:
- Article
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 5, p. 666
- By:
- Publication type:
- Article
Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. Suppl 2, p. 666
- By:
- Publication type:
- Article
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00833-z
- By:
- Publication type:
- Article
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00693-z
- By:
- Publication type:
- Article
EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.
- Published in:
- Science Immunology, 2020, v. 5, n. 48, p. 1, doi. 10.1126/sciimmunol.abc8413
- By:
- Publication type:
- Article
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 5, p. 594, doi. 10.3390/pharmaceutics16050594
- By:
- Publication type:
- Article
In Response.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2013, v. 89, n. 6, p. 1226, doi. 10.4269/ajtmh.13-0443b
- By:
- Publication type:
- Article
A Randomized, Double-Blind, Controlled Trial of the 17D Yellow Fever Virus Vaccine Given in Combination with Immune Globulin or Placebo: Comparative Viremia and Immunogenicity.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2013, v. 88, n. 1, p. 172, doi. 10.4269/ajtmh.2012.12-0179
- By:
- Publication type:
- Article
Detection of Anti-Yellow Fever Virus Immunoglobulin M Antibodies at 3-4 Years Following Yellow Fever Vaccination.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2012, v. 87, n. 6, p. 1112, doi. 10.4269/ajtmh.2012.12-0182
- By:
- Publication type:
- Article
Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine With MF59 Adjuvant.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 14, p. 1420
- By:
- Publication type:
- Article
Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 14, p. 1409, doi. 10.1001/jama.2014.12854
- By:
- Publication type:
- Article
Protein Dose-Sparing Effect of AS01<sub>B</sub> Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e405, doi. 10.1093/infdis/jiad434
- By:
- Publication type:
- Article
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 5, p. 1498, doi. 10.1093/infdis/jiad441
- By:
- Publication type:
- Article